1/88
Comprehensive vocabulary review flashcards for Audiology Exam 2, covering immittance audiometry, tympanometry types, evoked potentials (OAE, ABR), outer/middle/inner ear pathologies, CAPD, embryology, syndromic genetics, hearing aids, and implantable auditory devices.
Impedance
The opposition to the flow of acoustic energy through a physical system.
Admittance
A measure of how much acoustic energy successfully passes through a system.
Tympanometry
The measurement of acoustic admittance (mobility of the tympanic membrane and ossicular chain) as a function of air pressure changes applied in the external ear canal.
Tympanometric Probe Tone Frequencies
A probe tone of 226Hz is standard for adults, whereas a high-frequency probe tone of 1000Hz (1kHz) is required for infants under 6 months of age.
Tympanic Peak Pressure (TPP)
An indicator of middle ear pressure measured in daPa, representing the point of maximum sound admittance when pressure in the canal matches the pressure in the middle ear cavity; abnormal negative readings indicate Eustachian tube dysfunction.
Peak Compensated Static Acoustic Admittance (Ytm)
The maximum mobility or compliance of the tympanic membrane measured in cc (cm3) or mL; reduced values suggest scarring or otosclerosis, while abnormally elevated values indicate hypercompliance or disarticulation.
Ear Canal Volume (Vea / ECV)
The equivalent physical volume of air between the probe tip and the tympanic membrane, measured in mL.
Etiologies of Abnormally Large Ear Canal Volume (Vea)
A tympanic membrane perforation, a patent pressure equalization (PE) tube, or prior surgical alteration of the ear canal.
Etiologies of Abnormally Small Ear Canal Volume (Vea)
Impacted cerumen or debris occluding the canal, a middle ear space-occupying mass, atresia, or probe tip placement directly against the canal wall.
Tympanometric Width (TW)
The pressure interval (reported in daPa) determined at half the height of the tympanometric peak (21 of Ytm), calculated as the absolute difference between the two pressure points; abnormal width indicates accumulating or resolving middle ear fluid and is not related to TPP.
Compensated Tympanogram
A tympanometric tracing that subtracts the ear canal volume (Vea) to display only the acoustic admittance contributed by the middle ear system.
Type A Tympanogram
A normal tympanogram characterized by normal middle ear pressure, normal admittance/compliance, normal ear canal volume, and normal tympanometric width.
Type As Tympanogram
A shallow tympanogram characterized by normal middle ear pressure, normal canal volume, and normal width, but abnormally reduced peak admittance/compliance; associated with ossicular fixation (otosclerosis) or early/resolving otitis media with effusion.
Type Ad / Add Tympanogram
A hypercompliant deep tympanogram displaying normal middle ear pressure and canal volume, but abnormally high admittance/compliance; caused by ossicular chain disarticulation or a monomeric/flaccid tympanic membrane.
Type B Tympanogram
A flat tympanogram demonstrating no discernible peak and low-to-no admittance; normal Vea indicates middle ear effusion or severe negative pressure, large Vea indicates a perforation or patent PE tube, and small Vea indicates an occluding obstruction.
Type C Tympanogram
A tympanogram exhibiting normal admittance and normal canal volume, but significant negative middle ear peak pressure (<−100daPa); primarily indicates Eustachian tube dysfunction.
Acoustic Reflex
An involuntary contraction of the stapedius and tensor tympani middle ear muscles in response to loud acoustic stimulation (≥80dB), which stiffens the ossicular chain, attenuates vibrational energy transmission to the cochlea, and protects inner ear structures.
Acoustic Reflex Threshold (ART)
The lowest stimulus intensity level capable of eliciting a measurable decrease in middle ear admittance (≥0.02), measured with the ear pressurized to its TPP; used primarily to evaluate auditory nerve (CN VIII) and facial nerve (CN VII) pathways and rule out acoustic neuromas.
Otoacoustic Emissions (OAE)
An objective physiologic measure assessing the integrity and active micromechanical electromotility of outer hair cells (OHCs) on the basilar membrane.
Transient Evoked Otoacoustic Emissions (TEOAEs)
OAEs elicited by broadband clicks that simultaneously stimulate multiple frequency regions (∼1000 to 4000Hz); analyzed as a pass/fail screening using signal averaging, requiring high reproducibility and a Signal-to-Noise Ratio (SNR) greater than 6dB.
TEOAE Hearing Threshold Relationships
TEOAEs are present in 99% of ears with thresholds <20dB HL, may or may not be present from 25 to 35dB HL, and are completely absent (never present) when thresholds exceed 40dB HL.
Distortion Product Otoacoustic Emissions (DPOAEs)
Diagnostic, frequency-specific OAEs generated by presenting two pure tones simultaneously (f1 and f2) to evaluate frequencies from ∼1000 to 6000Hz; requires an SNR greater than 6dB for a valid response.
DPOAE Hearing Threshold Relationships
DPOAEs are present when hearing thresholds are <25dB HL, generally absent when thresholds exceed 40dB HL, and potentially present with reduced amplitude between 40 to 60dB HL.
Auditory Brainstem Response (ABR)
An objective electrophysiologic test measuring synchronous electrical action potentials generated along the auditory pathway from the cochlea through the brainstem within the first 10 to 12ms following stimulus presentation.
ABR Click Stimuli
Loud broadband acoustic pulses that stimulate a wide cochlear region to evaluate neural integrity and interpeak latencies across Waves I through VI; primarily applied in neuro-diagnostic testing for retrocochlear pathology.
ABR Tone Burst Stimuli
Frequency-specific filtered noise bursts presented at 500Hz, 1000Hz, 2000Hz, and 4000Hz used to estimate behavioral hearing thresholds by identifying the lowest intensity level that elicits Wave V.
ABR Neural Generators (Waves I–VI)
Wave I: Cochlea/distal CN VIII; Wave II: CN VIII (proximal); Wave III: Cochlear Nucleus; Wave IV: Superior Olivary Complex; Wave V: Lateral Lemniscus; Wave VI: Inferior Colliculus.
Anotia
A congenital disorder characterized by the complete absence of the auricle/pinna.
Microtia
A congenital deformity presenting as an abnormally small or malformed auricle/pinna.
Aural Atresia
A congenital absence or complete closure of the external auditory canal.
Canal Stenosis
An abnormal narrowing of the external auditory canal diameter, which may be congenital or acquired.
Auricular Hematoma
An acquired collection of blood beneath the perichondrium of the pinna resulting from trauma, commonly known as perichondrial hematoma or 'cauliflower ear.'
Otitis Externa
An infectious condition of the external ear canal skin, which may be viral, bacterial, or fungal in origin.
Exostosis
Benign bony outgrowths in the external auditory canal triggered by repeated, prolonged exposure to cold water, commonly termed 'surfer's ear.'
Osteoma
A benign bony neoplasm appearing as a solitary tumor within the external auditory canal.
Otitis Media with Effusion (OME)
An inflammatory condition characterized by the accumulation of fluid within the normally air-filled middle ear space.
Serous Otitis Media
A form of middle ear effusion where thin, non-infected fluid is present behind the tympanic membrane.
Acute Otitis Media
A rapid-onset middle ear pathology defined by the presence of infected fluid within the middle ear cavity.
Mucoid (Purulent) Otitis Media
A middle ear condition in which the tympanic cavity is filled with thick, purulent mucus or pus.
Glue Ear
A chronic presentation of middle ear effusion where the fluid becomes exceptionally thick and viscous, adhering directly to middle ear ossicles and structures.
Barotrauma (Tympanic Membrane)
Perforation or rupture of the tympanic membrane caused by rapid, extreme atmospheric pressure changes, such as from underwater diving or explosions.
Cholesteatoma
A benign, locally destructive pseudotumor in the middle ear space composed of desquamated epithelial cells and keratin.
Otosclerosis
An abnormal bone growth and remodeling disorder within the middle ear that fixes the stapes footplate in the oval window, producing conductive hearing loss.
Carhart's Notch
An artifactual sensorineural dip observed in bone conduction thresholds specifically at 2000Hz (2kHz) in patients with otosclerosis, resolving after stapes mobilization.
Stapedectomy
A surgical intervention for otosclerosis involving excision of the immobilized stapes, sealing the oval window with a tissue or fat pad, and anchoring a prosthetic wire to the incus.

Ossicular Discontinuity
The structural separation or disarticulation of the ossicular chain, secondary to physical trauma or tissue necrosis from chronic OME or cholesteatoma.
Glomus Tumor
A benign, highly vascularized, slow-growing middle ear tumor requiring surgical excision.
Noise-Induced Hearing Loss (NIHL)
A bilateral sensorineural hearing impairment caused by acoustic trauma or prolonged noise exposure, classically exhibiting a permanent 'noise notch' between 3000 to 6000Hz.
NIOSH Noise Exposure Standard
The National Institute for Occupational Safety and Health recommended maximum permissible occupational noise dosage of 8hours at 85dB within a 24-hour window.
OSHA Noise Exposure Standard
The Occupational Safety and Health Administration permissible exposure limit allowing a maximum dose of 8hours at 90dB within a 24-hour window.
Presbycusis
Progressive, age-related sensorineural hearing loss that initially compromises high frequencies before gradually spreading to lower spectral regions.
Meniere's Disease
An inner ear disorder resulting from endolymphatic hydrops (excess fluid volume in the scala media and vestibular labyrinth), typically causing fluctuating unilateral low-frequency sensorineural hearing loss, vertigo, and tinnitus.
Aminoglycoside Ototoxicity
Cochlear damage induced by potent broadband '-mycin' antibiotic drugs.
Chemotherapeutic Platinum Ototoxicity
Severe, irreversible sensorineural hearing damage caused by platinum-based chemotherapeutic agents (Cisplatin and Carboplatin), initiating as a precipitous high-frequency loss that progresses toward lower frequencies.
Loop Diuretic Ototoxicity
Hearing impairment caused by diuretic medications (e.g., Furosemide, Bumetanide) prescribed for edema, congestive heart failure, and renal disease.
Salicylate Ototoxicity
Cochlear toxicity resulting from high doses of anti-inflammatory medications like aspirin, typically producing a reversible, flat mild-to-moderate sensorineural hearing loss.
Acoustic Neuroma
A benign, slow-growing schwannoma on the vestibular division of Cranial Nerve VIII, classically presenting with unilateral high-frequency sensorineural hearing loss, poor word recognition, tinnitus, and abnormal ABR/acoustic reflex findings.
Central Auditory Processing Disorder (CAPD)
A neural deficit in auditory signal handling within the central nervous system that impairs processing of auditory stimuli along brain pathways, occurring independently of higher-order cognitive, language, or intellectual disorders.
Decoding Deficits (CAPD)
The 'truest' auditory-specific CAPD profile, localized to the left hemisphere or high brainstem, characterized by an inability to extract fine pitch, loudness, and timing cues, creating discrimination breakdown.
Integration Deficits (CAPD)
A cortical processing deficit marked by disrupted interhemispheric communication across the corpus callosum; patients cannot synthesize complex auditory information and become overwhelmed when multi-faceted data is presented rapidly.
Prosodic Deficits (CAPD)
A right-hemisphere central processing deficit marked by the inability to detect intonation contours, pitch rises and falls, or syllabic emphasis.
Diagnostic Criteria for CAPD Test Batteries
A clinical rule stating that if only a single test in a behavioral battery is abnormal, or conversely if all tasks across all tests fail, the condition is probably not true CAPD.
Bottom-Up CAPD Intervention
Stimulus-driven therapy focusing on auditory perceptual training, acoustic skill remediation, and environmental/assistive acoustic modifications.
Top-Down CAPD Intervention
Strategy-driven therapy utilizing cognitive, linguistic, and metacognitive compensatory techniques, educational modifications, and workplace accommodations.
Auditory Embryology: Month 1 & Month 2 (Peck Timeline)
In January (Month 1), the Eustachian tube begins forming; in February (Month 2), the vestibule separates from the cochlea, ossicular development begins, and the external canal starts developing.
Auditory Embryology: Month 3 to Month 5 (Peck Timeline)
In March (Month 3), inner and middle ear structures achieve adult form; in April–May (Months 4–5), cochlear hair cell differentiation occurs rapidly, and the fully formed ossicles begin ossifying.
Auditory Embryology: Month 6 to Month 8 (Peck Timeline)
In June (Month 6), the inner ear reaches near-adult size and the pinna attains adult form; in July (Month 7), initial auditory experiences occur and ossicles are nearly ossified; in August (Month 8), the tympanic cavity and ear canal open.
Usher Syndrome
The most common autosomal recessive syndromic hearing loss, presenting with sensorineural hearing loss and retinitis pigmentosa leading to progressive night blindness and visual field constriction.
Usher Syndrome Subtypes (USH1, USH2, USH3)
USH1 exhibits congenital severe-to-profound SNHL, vestibular dysfunction, and early night blindness; USH2 has congenital moderate-to-severe SNHL, normal vestibular function, and vision loss onset between ages 10 and 40; USH3 is progressive SNHL appearing in the third decade with variable vestibular and retinal deficits.
Waardenburg Syndrome
An autosomal dominant syndrome accounting for 1 to 3% of congenital hearing loss, marked by sensorineural loss and pigmentation anomalies of the iris, hair (white forelock), skin, and stria vascularis, classified into types W1–W4.
CHARGE Syndrome
An autosomal dominant disorder defined by Coloboma (iris/eyelid gap), Heart defects, Atresia of the choanae, Retarded growth/development, Genital abnormalities, and Ear/vestibular abnormalities.
Stickler Syndrome
A dominant or recessive hereditary connective tissue disorder involving collagen gene mutations, causing severe myopia, joint laxity, orofacial clefting, and sensorineural or conductive hearing loss.
Treacher Collins Syndrome
An autosomal dominant syndrome disrupting midface and mandibular tissue development, causing conductive hearing loss in approximately half of patients due to pinna microtia/atresia and ossicular dysmorphology.
Pendred Syndrome
The most prevalent autosomal recessive syndromic deafness condition, characterized by thyroid goiter and dysharmonic inner ear development, classically Mondini malformation.
Mondini Malformation
An incomplete cochlear partition malformation featuring an insufficient number of turns (fewer than the normal 221 turns), associated with Pendred syndrome.

Audiometric Candidacy for Hearing Aids
A minimum thresholds deficit of mild sensorineural loss across 500 to 4000Hz, adequate word recognition scores, tolerable Loudness Discomfort Levels (LDL/UCL), and consideration of patient motivation and medical clearance.
Hearing Aid Fitting Workflow
The seven-step process comprising Assessment, Treatment Planning, Selection, Development, Verification, Orientation, and Validation.

Real-Ear Verification (Probe Microphone Measurement)
The gold-standard objective verification technique where a thin silicone probe tube microphone is positioned inside the ear canal to measure exact sound pressure level (SPL) output delivered by the hearing aid.
Test Box Verification
An electroacoustic verification measure wherein the hearing aid is attached to a 2-cc ear simulator/coupler in an isolated, sound-treated chamber to estimate prescriptive gain compliance prior to patient placement.
Wide Dynamic Range Compression (WDRC)
A digital processing circuit that continuously regulates amplification, providing greater gain for low-intensity sounds and reduced gain for high-intensity sounds to preserve normal loudness perception without distortion.
Hearing Aid Data Logging
An onboard digital monitoring feature tracking daily hours of hearing aid wear, user volume adjustments, program selections, and listening acoustic environments.
Client Oriented Scale of Improvement (COSI)
A standardized clinical self-report outcome tool where patients identify specific listening goals prior to amplification and rate their degree of change and final listening ability over time.

Percutaneous Bone Anchored Implant (BAI)
A direct-drive bone conduction processor attached via a titanium abutment that protrudes through the skin, offering superior high-frequency sound transmission but carrying increased infection vulnerability.
Transcutaneous Bone Anchored Implant (BAI)
A skin-drive bone conduction processor attached via a magnetic coupling situated entirely beneath the intact scalp, having lower infection rates but experiencing attenuation of high-frequency energy.
Bone Anchored Implant (BAI) Candidacy
Patients with conductive or mixed hearing loss with an air-bone gap of at least 30dB, Single-Sided Deafness (SSD) acting as a CROS system, skull bone thickness of at least 2.5mm, and a minimum age of 5years.
Middle Ear Implant (MEI) Candidacy
Adults exhibiting stable moderate-to-severe sensorineural hearing loss, word recognition scores between 40 to 60%, and anatomical or dermatological contraindications to conventional hearing aids.
Cochlear Implant (CI)
A surgically implanted neural prosthesis that bypasses outer, middle, and damaged cochlear hair cells to provide direct electrical stimulation to the auditory nerve (CN VIII).
Hybrid Cochlear Implant
A specialized device combining conventional acoustic amplification for preserved low-frequency hearing with electrical cochlear implant stimulation for non-functional high frequencies.
Cochlear Implant (CI) Candidacy Criteria
Patients at least 1year of age with severe-to-profound bilateral sensorineural hearing loss receiving minimal benefit from traditional hearing aids, supported by CT or MRI verification of inner ear patency and auditory nerve presence.